Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise.

Oral ondansetron for paediatric gastroenteritis in primary care: a randomised controlled trial

Telmisartan inhibits the NLRP3 inflammasome by activating the PI3K pathway in neural stem cells injured by oxygen-glucose deprivation (OGD)

Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI): a meta-analysis of randomized controlled trials with GRADE qualification of available evidence

Vildagliptin is a safe and powerful oral antidiabetic drug for elderly adults with type 2 diabetes

The efficacy and safety of azithromycin in chronic respiratory diseases related cough

The impact of vildagliptin on the daily glucose profle and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE—A multicenter randomized controlled trial

Reduced Mortality With Ondansetron Use in SARS-CoV2-Infected Inpatients

Comparative clinical study evaluating the effect of adding vildagliptin versus glimepiride to ongoing metformin therapy on diabetic patients with symptomatic coronary artery disease (CAD)